Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1216824.RAUCGsOr8V5sBu5raqEoZjHl_Uo2CrXnxz6fklwS7eR5Q130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1216824.RAUCGsOr8V5sBu5raqEoZjHl_Uo2CrXnxz6fklwS7eR5Q130_assertion type Assertion NP1216824.RAUCGsOr8V5sBu5raqEoZjHl_Uo2CrXnxz6fklwS7eR5Q130_head.
- NP1216824.RAUCGsOr8V5sBu5raqEoZjHl_Uo2CrXnxz6fklwS7eR5Q130_assertion description "[There is an increased risk of CML in subjects with (i) deletions of genes encoding glutathione-S-transferase (GST)-?1 (GSTT1) and -?1, (GSTM1) and (ii) the GST-?1 (GSTP1) single-nucleotide polymorphism (SNP) Ile105Val (GSTP1*B; rs1695); however, their effects on imatinib treatment outcome are not known.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1216824.RAUCGsOr8V5sBu5raqEoZjHl_Uo2CrXnxz6fklwS7eR5Q130_provenance.
- NP1216824.RAUCGsOr8V5sBu5raqEoZjHl_Uo2CrXnxz6fklwS7eR5Q130_assertion evidence source_evidence_literature NP1216824.RAUCGsOr8V5sBu5raqEoZjHl_Uo2CrXnxz6fklwS7eR5Q130_provenance.
- NP1216824.RAUCGsOr8V5sBu5raqEoZjHl_Uo2CrXnxz6fklwS7eR5Q130_assertion SIO_000772 25188725 NP1216824.RAUCGsOr8V5sBu5raqEoZjHl_Uo2CrXnxz6fklwS7eR5Q130_provenance.
- NP1216824.RAUCGsOr8V5sBu5raqEoZjHl_Uo2CrXnxz6fklwS7eR5Q130_assertion wasDerivedFrom befree-2016 NP1216824.RAUCGsOr8V5sBu5raqEoZjHl_Uo2CrXnxz6fklwS7eR5Q130_provenance.
- NP1216824.RAUCGsOr8V5sBu5raqEoZjHl_Uo2CrXnxz6fklwS7eR5Q130_assertion wasGeneratedBy ECO_0000203 NP1216824.RAUCGsOr8V5sBu5raqEoZjHl_Uo2CrXnxz6fklwS7eR5Q130_provenance.